Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole fixed-dose trial in pediatric Tourette syndrome
2008-000343-33Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of pramipexole in Tourette syndrome (TS) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline to Week 8 in Yale Global Tic Severity Scale Total Tic Score. Started Jun 2009; status: completed.
02
Drugs
pramipexole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on 2008-000343-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000343-33.